| Ms Paula Nash, | |
|
120 S Hays St, Bel Air, MD 21014-3615 | |
| (410) 877-1000 | |
| Not Available |
| Full Name | Ms Paula Nash |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 120 S Hays St, Bel Air, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417428418 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 10950 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Paula Nash, 604 Camelot Dr, Bel Air, MD 21015-5835 Ph: (410) 688-3034 | Ms Paula Nash, 120 S Hays St, Bel Air, MD 21014-3615 Ph: (410) 877-1000 |
News Archive
U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year.
By engineering an on/off switch into a weakened form of HIV, University of Nebraska-Lincoln researchers have enhanced the safety and effectiveness of a potential vaccine for the virus that has killed approximately 35 million people during the past 35 years.
The Regence Foundation has announced a new award that recognizes leadership in palliative care, a specialized field of health care that relieves suffering and improves quality of life for patients with advanced illness.
A single treatment using an optimized, targeted form of faecal microbiota transplantation (FMT) produces sustained clinical and cognitive improvements, according to the results of a long-term follow-up of patients with liver cirrhosis and hepatic encephalopathy (HE) who had participated in a short-term study.
ACCESS PHARMACEUTICALS, INC. announced today that it initiated an internal pre-licensing program to confirm the utility of its proprietary Cobalamin (vitamin B12) platform technology for targeted delivery of siRNA therapies. The program is considered important because, despite the widely publicized potential of RNA therapy, researchers up to now have been stymied in their efforts to design a pharmaceutical product that efficiently transports siRNA therapeutics into the cells they are designed to inhibit or kill.
› Verified 9 days ago
Julyette E Berry, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1208 E Churchville Rd Ste 300, Bel Air, MD 21014 Phone: 301-204-6199 | |
Ms. Johanna S Wayne, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 336 S Main St Ste 2ca, Bel Air, MD 21014 Phone: 410-688-1058 | |
Mrs. Lydia Ivette Holloway, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 22 Linwood Ave Ste B, Bel Air, MD 21014 Phone: 443-629-8858 | |
Ms. Carla Battle Nolan, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 336 S Main St, Bel Air, MD 21014 Phone: 410-836-0820 | |
Rosemary A Dehn, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 22 Linwood Ave, Bel Air, MD 21014 Phone: 410-688-1007 | |
Kristle M Fullerton, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 802 Baltimore Pike, Bel Air, MD 21014 Phone: 443-643-2422 | |
Nickolaus King, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4c North Ave Ste 423, Bel Air, MD 21014 Phone: 410-449-4955 Fax: 443-787-0306 |